Abstract:Abstract Background The gut microbiome represents a promising avenue to elucidate distinct underlying pathophysiology in Crohn's disease (CD).Our aim was to evaluate the composition of the microbiota in Inflammatory B1 and Stricturing B2 Phenotype. Methods We performed 16S ribosomal RNA sequencing on stool samples of 108 patients (64 B1 and 44 B2) included in the Chinese CD cohort and 58 health controls without any inflammatory disorder, in order to explore the structural composition of gut microbiota in different phenotype of CD. Results Comparison of gut microbiota between patients with CD and healthy controls, α diversity and β diversity were statistically different. At the genus level, compared with the normal group, the abundance of Blautia, Bifidobacterium, Faecalibacterium, Collinsella, Coprococcus, Gemmiger, Prevotella, Dialister, Roseburia and Clostridium were decreased significantly in the CD group. In contrast, the abundance of Bacteroides, Ruminococcus, Streptococcus, Enterococcus, Dorea, Escherichia, Phascolarctobacterium, Veillonella and Eubacterium increased significantly. Compared with B1 phenotype, Streptococcus, Collinsella, Veillonella, Coprococcus and Gemmiger were significant decreased in B2 phenotype group. However, Ruminococcus, Dorea, Lactobacillus and Dialister were significant increased. Conclusion Comparison of gut microbiota between patients with CD and healthy controls, α diversity and β diversity were statistically different. At the genus level, compared with the normal group, the abundance of Blautia, Bifidobacterium, Faecalibacterium, Collinsella, Coprococcus, Gemmiger, Prevotella, Dialister, Roseburia and Clostridium were decreased significantly in the CD group. In contrast, the abundance of Bacteroides, Ruminococcus, Streptococcus, Enterococcus, Dorea, Escherichia, Phascolarctobacterium, Veillonella and Eubacterium increased significantly. Compared with B1 phenotype, Streptococcus, Collinsella, Veillonella, Coprococcus and Gemmiger were significant decreased in B2 phenotype group. However, Ruminococcus, Dorea, Lactobacillus and Dialister were significant increased.

What problem does this paper attempt to address?

This paper aims to explore the differences in the gut microbiome between the inflammatory B1 phenotype and the stenotic B2 phenotype in Crohn's Disease (CD). Specifically, researchers hope to reveal their potentially different mechanisms in disease development by analyzing the gut microbial composition of patients with these two different phenotypes. By comparing fecal samples from 108 CD patients (64 with the B1 phenotype and 44 with the B2 phenotype) with those from 58 healthy controls, the researchers evaluated the structural composition of gut microbes in these samples using 16S rRNA sequencing technology. The research results show that, compared with the healthy control group, there are significant differences in both α - diversity and β - diversity in CD patients. At the genus level, compared with the normal group, the abundances of some bacteria in the CD group are significantly reduced, such as Blautia, Bifidobacterium, Faecalibacterium, Collinsella, Coprococcus, Gemmiger, Prevotella, Dialister, Roseburia and Clostridium; while the abundances of some other bacteria are significantly increased, such as Bacteroides, Ruminococcus, Streptococcus, Enterococcus, Dorea, Escherichia, Phascolarctobacterium, Veillonella and Eubacterium. Furthermore, when comparing the two phenotypes B1 and B2, the study found that in the B2 phenotype, the abundances of Streptococcus, Collinsella, Veillonella, Coprococcus and Gemmiger are significantly lower than those in the B1 phenotype; conversely, the abundances of Ruminococcus, Dorea, Lactobacillus and Dialister are significantly higher than those in the B1 phenotype. In conclusion, this study not only reveals the significant differences in gut microbial composition between CD patients and healthy individuals, but also discovers the specific changes in the microbiome among different clinical phenotypes, which may provide a new perspective for understanding the different pathogenesis of CD and contribute to the development of personalized treatment strategies for specific phenotypes in the future.

P1241 Distinct gut microbiota in Crohn's Disease between inflammatory B1 and stricturing B2 phenotype